Publications

New arrangements for migalastat (Galafold®) for treatment of Fabry Disease

This fact sheet is for current and future patients with Fabry disease explaining how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS. The fact sheet further provides clarity on future access arrangements via the PBS.

Downloads

New arrangements for migalastat (Galafold) – patient fact sheet

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
Fact sheet
Audience:
Health sector
Language:
English
Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.